In accordance with our results, it is reported that the inhibition of MCT1 by a pharmacological approach with AZD3965 resulted in a delay in tumor growth together with an increment of glycolysis in human tumor cell lines and cancer xenografts of small cell lung tumor. Here, SLC16A1 is linked to neoplasm.